TY 2023 Form 990PF

- TIN:

Form990-PF

Department of the Treasury
Internal Revenue Service

Return of Private Foundation

or Section 4947(a)(1) Trust Treated as Private Foundation

Do not enter social security numbers on this form as it may be made public.
right arrow

Go to www.irs.gov/Form990PF for instructions and the latest information.

OMB No. 1545-0047

2023

Open to Public Inspection

For calendar year 2023, or tax year beginning 01-01-2023 , and ending 12-31-2023

Name of foundation
DONALD WEESNER CHARITABLE TR UA

Number and street (or P.O. box number if mail is not delivered to street address)PO BOX 0634
Room/suite

City or town, state or province, country, and ZIP or foreign postal code
MILWAUKEE, WI532010634

A Employer identification number

41-6463406

B Telephone number (see instructions)

(651) 466-8040

C If exemption application is pending, check here right arrow

G Check all that apply: Initial returnInitial return of a former public charity
Final returnAmended return
Address change Name change

D 1. Foreign organizations, check here............. right arrow

2. Foreign organizations meeting the 85%
test, check here and attach computation ... right arrow

E If private foundation status was terminated
under section 507(b)(1)(A), check here ....... right arrow

H Check type of organization: Section 501(c)(3) exempt private foundation
Section 4947(a)(1) nonexempt charitable trust Other taxable private foundation

F If the foundation is in a 60-month termination
under section 507(b)(1)(B), check here ....... right arrow

I Fair market value of all assets at end
of year (from Part II, col. (c),
line 16) right arrow

$13,447,215J Accounting method: Cash Accrual
Other (specify)
(Part I, column (d) must be on cash basis.)

	Analysis of Revenue and Expenses (The total of amounts in columns (b), (c), and (d) may not necessarily equal the amounts in column (a) (see instructions).)	(a) Revenue and expenses per books		(b) Net investment income	(c) Adjusted net income	(d) Disbursements for charitable purposes (cash basis only)


1	Contributions, gifts, grants, etc., received (attach schedule)
2	Check .............
3	Interest on savings and temporary cash investments
4	Dividends and interest from securities...	354,138		348,685
5a	Gross rents............
b	Net rental income or (loss)
6a	Net gain or (loss) from sale of assets not on line 10		157,928
b	Gross sales price for all assets on line 6a 943,302
7	Capital gain net income (from Part IV, line 2)...			157,928
8	Net short-term capital gain.........				0
9	Income modifications...........
10a	Gross sales less returns and allowances
b	Less: Cost of goods sold....
c	Gross profit or (loss) (attach schedule).....
11	Other income (attach schedule).......	List of Attached Documents: // Content	26,426	22,120
12	Total. Add lines 1 through 11........	538,492		528,733
13	Compensation of officers, directors, trustees, etc.	113,530		111,627		11,353
14	Other employee salaries and wages......			0	0	0
15	Pension plans, employee benefits.......			0	0
16a	Legal fees (attach schedule).........					0
b	Accounting fees (attach schedule).......	List of Attached Documents: // Content	1,500	0	0	1,500
c	Other professional fees (attach schedule)....	List of Attached Documents: // Content	3,692	3,692		0
17	Interest...............					0
18	Taxes (attach schedule) (see instructions)...	List of Attached Documents: // Content	3,759	3,759		0
19	Depreciation (attach schedule) and depletion...		0	0
20	Occupancy..............
21	Travel, conferences, and meetings.......			0	0
22	Printing and publications..........			0	0
23	Other expenses (attach schedule).......	List of Attached Documents: // Content	21,442	2		21,440
24	Total operating and administrative expenses.
	Add lines 13 through 23..........	143,923		119,080	0	34,293
25	Contributions, gifts, grants paid.......	644,000				644,000
26	Total expenses and disbursements. Add lines 24 and 25	787,923		119,080	0	678,293
27	Subtract line 26 from line 12:
a	Excess of revenue over expenses and disbursements	-249,431
b	Net investment income (if negative, enter -0-)			409,653
c	Adjusted net income (if negative, enter -0-)...				0

For Paperwork Reduction Act Notice, see instructions.

Cat. No. 11289X Form 990-PF (2023)

Form 990-PF (2023)

Page 2

Part II		Balance Sheets	Beginning of year	End of year
Part II		Balance Sheets	(a) Book Value	(b) Book Value	(c) Fair Market Value
	1	Cash—non-interest-bearing.............
	2	Savings and temporary cash investments.........	1,022,178	394,417	394,417
	3	Accounts receivable
		Less: allowance for doubtful accounts		0	0
	4	Pledges receivable
		Less: allowance for doubtful accounts
	5	Grants receivable.................
	6	Receivables due from officers, directors, trustees, and other
		disqualified persons (attach schedule) (see instructions).....
	7	Other notes and loans receivable (attach schedule)
		Less: allowance for doubtful accounts 0
	8	Inventories for sale or use..............
	9	Prepaid expenses and deferred charges..........
	10a	Investments—U.S. and state government obligations (attach schedule)
	b	Investments—corporate stock (attach schedule).......	2,759,199	List of Attached Documents: // Content 2,856,423	5,959,655
	c	Investments—corporate bonds (attach schedule).......	751,000	List of Attached Documents: // Content 751,000	871,672
	11	Investments—land, buildings, and equipment: basis
		Less: accumulated depreciation (attach schedule)
	12	Investments—mortgage loans.............
	13	Investments—other (attach schedule)..........	5,861,859	List of Attached Documents: // Content 6,140,118	6,206,981
	14	Land, buildings, and equipment: basis
		Less: accumulated depreciation (attach schedule)
	15	Other assets (describe )	List of Attached Documents: // Content 12,071	List of Attached Documents: // Content 14,490	List of Attached Documents: // Content 14,490
	16	Total assets (to be completed by all filers—see the
		instructions. Also, see page 1, item I)	10,406,307	10,156,448	13,447,215
	17	Accounts payable and accrued expenses..........
	18	Grants payable.................
	19	Deferred revenue.................
	20	Loans from officers, directors, trustees, and other disqualified persons
	21	Mortgages and other notes payable (attach schedule)......
	22	Other liabilities (describe )
	23	Total liabilities (add lines 17 through 22).........		0
		Foundations that follow FASB ASC 958, check here
		and complete lines 24, 25, 29 and 30.
	24	Net assets without donor restrictions...........
	25	Net assets with donor restrictions............
		Foundations that do not follow FASB ASC 958, check here
		and complete lines 26 through 30.
	26	Capital stock, trust principal, or current funds........	10,406,307	10,156,448
	27	Paid-in or capital surplus, or land, bldg., and equipment fund
	28	Retained earnings, accumulated income, endowment, or other funds
	29	Total net assets or fund balances (see instructions).....	10,406,307	10,156,448
	30	Total liabilities and net assets/fund balances (see instructions).	10,406,307	10,156,448

Part III

Analysis of Changes in Net Assets or Fund Balances

Total net assets or fund balances at beginning of year—Part II, column (a), line 29 (must agree with end-of-year figure reported on prior year’s return) ...............

10,406,307

Enter amount from Part I, line 27a .....................

-249,431

Other increases not included in line 2 (itemize) right arrow

List of Attached Documents:

// Content

Add lines 1, 2, and 3 ..........................

10,156,881

Decreases not included in line 2 (itemize) right arrow

List of Attached Documents:

// Content

433

Total net assets or fund balances at end of year (line 4 minus line 5)—Part II, column (b), line 29 .

10,156,448

Form 990-PF (2023)

Page 3

Part IV

Capital Gains and Losses for Tax on Investment Income

(a) List and describe the kind(s) of property sold (e.g., real estate, 2-story brick warehouse; or common stock, 200 shs. MLC Co.)		(b) How acquired P—Purchase D—Donation	(c) Date acquired (mo., day, yr.)	(d) Date sold (mo., day, yr.)
1 a	21. BWX TECHNOLOGIES INC			2023-01-05
b	2. CACI INTERNATIONAL INC CL A		2022-09-12	2023-01-05
c	7. PORTLAND GENERAL ELECTRIC CO		2022-04-06	2023-01-05
d	17. REVANCE THERAPEUTICS INC		2022-10-06	2023-01-09
e	10. REVANCE THERAPEUTICS INC			2023-01-10
	13. AZEK CO INC CL A			2023-01-12
	19. PORTLAND GENERAL ELECTRIC CO		2022-04-06	2023-01-13
	2. SILICON LABORATORIES INC		2019-05-28	2023-01-13
	9. COHEN STEERS INC			2023-01-17
	3. CONMED CORP		2021-11-04	2023-01-17
	3. COHEN STEERS INC		2021-03-11	2023-01-18
	2. CONMED CORP			2023-01-18
	9. FOCUS FINANCIAL PARTNERS A		2020-07-09	2023-01-18
	1. MESA LABS INC		2019-12-18	2023-01-18
	4. REVANCE THERAPEUTICS INC		2022-09-12	2023-01-18
	17. HELEN OF TROY LTD			2023-01-18
	4. COHEN STEERS INC			2023-01-19
	16. CROCS INC		2022-11-15	2023-01-19
	1. MESA LABS INC		2019-12-18	2023-01-19
	3. POWER INTEGRATIONS INC		2022-11-15	2023-01-19
	6. SILICON LABORATORIES INC		2019-05-28	2023-01-19
	.496 SUMMIT MATERIALS INC CL A		2021-03-04	2023-01-19
	5. HOWARD HUGHES CORP/THE		2022-01-26	2023-01-20
	8. REVANCE THERAPEUTICS INC			2023-01-20
	2. SITIME CORP		2022-05-19	2023-01-20
	14. REVANCE THERAPEUTICS INC			2023-01-24
	1. TG THERAPEUTICS INC		2023-01-13	2023-01-24
	2.00021 CALIX NETWORKS INC			2023-01-25
	4.99979 CALIX NETWORKS INC		2022-10-26	2023-01-25
	85. COMSTOCK RESOURCES INC			2023-01-25
	1. SILICON LABORATORIES INC		2019-05-28	2023-01-25
	2. EASTERN BANKSHARES INC		2022-10-28	2023-01-27
	60. EASTERN BANKSHARES INC			2023-01-27
	4. VENTYX BIOSCIENCES INC		2022-12-21	2023-01-27
	16. CRYPORT INC		2022-04-05	2023-01-30
	1. CRYPORT INC		2020-11-23	2023-01-30
	5. MA COM TECH SOLUTIONS HLDNGS INC		2021-04-12	2023-01-30
	7. BLUEPRINT MEDICINES CORP		2022-08-25	2023-01-31
	54. EASTERN BANKSHARES INC			2023-01-31
	63. TG THERAPEUTICS INC			2023-02-02
	7. BLACKLINE INC			2023-02-03
	1. EARTHSTONE ENERGY INC CL A		2022-03-02	2023-02-03
	147. EARTHSTONE ENERGY INC CL A			2023-02-03
	16. LIVENT CORP		2022-05-04	2023-02-03
	15. MP MATLS CORP		2021-03-18	2023-02-03
	366. HORIZON THERAPEUTICS PLC		2020-06-29	2023-02-03
	15. ARROWHEAD PHARMACEUTICALS INC			2023-02-07
	4. ASBURY AUTOMOTIVE GROUP			2023-02-07
	9. BJS WHOLESALE CLUB HOLDINGS INC		2020-09-23	2023-02-07
	13. HILTON GRAND VACATIONS		2022-04-21	2023-02-07
	16. HILTON GRAND VACATIONS			2023-02-07
	3. MESA LABS INC		2019-12-18	2023-02-07
	13. OMNICELL INC COM			2023-02-07
	56. TG THERAPEUTICS INC			2023-02-07
	33. VARONIS SYSTEMS INC			2023-02-07
	7. WORKIVA INC			2023-02-07
	3. AMN HEALTHCARE SERVICES INC		2023-01-11	2023-02-08
	8. ASGN INC			2023-02-08
	1. MERIT MEDICAL SYSTEMS INC COM		1911-11-11	2023-02-17
	3. TRANSMEDICS GROUP INC		2023-01-31	2023-02-23
	2. NOVANTA INC		2022-10-04	2023-02-24
	27. VIKING THERAPEUTICS INC		2022-12-21	2023-02-24
	3. AMBARELLA INC		2022-05-17	2023-02-24
	3. NOVANTA INC		2022-10-04	2023-02-28
	8. AXONICS MODULATION TECHNOLOG		2022-08-12	2023-03-06
	2. KARUNA THERAPEUTICS INC			2023-03-06
	15. VIKING THERAPEUTICS INC			2023-03-06
	27. COLUMBIA BKG SYS INC			2023-03-09
	7. INDEPENDENT BK CORP MASS		2019-05-28	2023-03-09
	238. MCCORMICK & CO INC COM NON VTG		2017-08-14	2023-03-09
	30. BROOKLINE BANCORP INC		2019-05-28	2023-03-10
	4. EVERCORE INC		2023-02-09	2023-03-10
	18. FOCUS FINANCIAL PARTNERS A			2023-03-10
	53. FOCUS FINANCIAL PARTNERS A			2023-03-10
	1. GSE HOLDING INC		1911-11-11	2023-03-10
	7. AXSOME THERAPEUTICS INC			2023-03-13
	169. FIRST REPUBLIC BANK SAN FRAN			2023-03-13
	1. MEDPACE HLDGS INC		2023-01-11	2023-03-13
	35. DIAMONDROCK HOSPITALITY CO		2023-02-02	2023-03-15
	16. AMYLYX PHARMACEUTICALS INC COM		2022-10-10	2023-03-20
	74. DIAMONDROCK HOSPITALITY CO		2023-02-02	2023-03-20
	127. DIODES INC		2019-08-05	2023-03-20
	50. GRIFFON CORP			2023-03-20
	17. H E EQUIPMENT SERVICES INC			2023-03-20
	16. HEALTHEQUITY INC			2023-03-20
	46. INDEPENDENCE REALTY TRUST IN			2023-03-20
	35. MONOLITHIC POWER SYSTEMS INC		2016-10-04	2023-03-20
	4.00006 SPS COMMERCE INC		2021-09-29	2023-03-20
	6.99994 SPS COMMERCE INC		2021-09-29	2023-03-20
	17. TEREX CORP			2023-03-20
	13. VENTYX BIOSCIENCES INC			2023-03-20
	6. WINTRUST FINANCIAL CORP		2023-02-07	2023-03-20
	8. AKERO THERAPEUTICS INC		2022-12-16	2023-03-22
	15. AMERICAN STATES WATER CO			2023-03-23
	4. BELLRING DISTR LLC COMMON STOCK		2022-09-14	2023-03-23
	18. HELMERICH PAYNE INC		2022-11-10	2023-03-27
	24. RANGER OIL CORP		2023-02-14	2023-03-27
	82. WILLSCOT MOBIL MINI HLDNG CORP COM		2021-09-16	2023-03-27
	25. SOVOS BRANDS INC COM		2023-03-20	2023-03-28
	14. AAON INC		2022-04-22	2023-04-05
	14. COMFORT SYS USA INC		2021-03-04	2023-04-05
	154. COPART INC COM		2017-12-11	2023-04-12
	14. DECKERS OUTDOOR CORP		2022-07-20	2023-04-12
	56. KEYSIGHT TECHNOLOGIES INC		2018-12-24	2023-04-12
	5. PROMETHEUS BIOSCIENCES INC			2023-04-17
	9. WERNER ENTERPRISES INC		2023-02-02	2023-04-18
	16. WERNER ENTERPRISES INC			2023-04-18
	472. MASCO CORP COM		2020-12-15	2023-04-19
	406. TRIMBLE NAV LTD COM W/RIGHTS ATTACHED EX		2022-04-11	2023-04-19
	21. EXTREME NETWORKS INC COM W/RIGHTS ATTACH		2022-12-08	2023-04-21
	28. LIVENT CORP			2023-04-21
	32. VIKING THERAPEUTICS INC			2023-04-21
	1. SHOCKWAVE MEDICAL INC		2022-11-08	2023-04-24
	30. VERONA PHARMA PLC A D R			2023-04-24
	15. MAXLINEAR INC CLASS A		2020-06-16	2023-04-26
	7. WALKER & DUNLOP INC			2023-04-26
	4. SITIME CORP			2023-04-27
	12. CACTUS INC A		2022-07-28	2023-05-02
	14. STAG INDUSTRIAL INC			2023-05-02
	4. WALKER & DUNLOP INC		2023-01-18	2023-05-03
	11. WALKER & DUNLOP INC		2020-05-08	2023-05-03
	16. ASGN INC			2023-05-04
	124. BROOKLINE BANCORP INC		2019-05-28	2023-05-04
	8. AMBARELLA INC			2023-05-04
	40. NEW JERSEY RESOURCES CORP			2023-05-08
	2. SHOCKWAVE MEDICAL INC		2022-11-11	2023-05-08
	13. SCORPIO TANKERS INC		2023-03-21	2023-05-09
	1. SHOCKWAVE MEDICAL INC		2022-11-11	2023-05-11
	8. VIKING THERAPEUTICS INC			2023-05-11
	7. BALCHEM CORP		2022-05-25	2023-05-18
	2. BALCHEM CORP		2019-05-28	2023-05-18
	2. CHESAPEAKE UTILITIES CORP		2022-03-07	2023-05-24
	7. MERITAGE HOMES CORPORATION			2023-05-24
	141. SOVOS BRANDS INC COM			2023-05-24
	54. DAY ONE BIOPHARMACEUTICALS INC COM			2023-05-25
	20. OPTION CARE HEALTH INC			2023-05-30
	5. CHESAPEAKE UTILITIES CORP			2023-05-31
	14. BJS WHOLESALE CLUB HOLDINGS INC			2023-06-02
	7. BJS WHOLESALE CLUB HOLDINGS INC		2020-06-29	2023-06-05
	9. BJS WHOLESALE CLUB HOLDINGS INC		2020-06-29	2023-06-06
	2. SHOCKWAVE MEDICAL INC		2022-05-17	2023-06-06
	15. BJS WHOLESALE CLUB HOLDINGS INC		2020-06-29	2023-06-07
	4. BLACKLINE INC		2022-12-15	2023-06-07
	9. BLACKLINE INC		2020-06-24	2023-06-07
	2. SHOCKWAVE MEDICAL INC			2023-06-07
	1. SHOCKWAVE MEDICAL INC		2022-05-17	2023-06-07
	16. CHEESECAKE FACTORY INC		2023-02-02	2023-06-08
	13. SCORPIO TANKERS INC			2023-06-08
	9. RBC BEARINGS INC			2023-06-09
	43. STRIDE INC			2023-06-15
	49. IVERIC BIO INC			2023-06-16
	4. MP MATLS CORP		2022-10-20	2023-06-20
	40. MP MATLS CORP			2023-06-20
	156. NEUROCRINE BIOSCIENCES INC COM W/RTS EXP		2020-07-15	2023-06-22
	13. SAIA INC		2022-01-25	2023-06-22
	29. MCGRATH RENTCORP			2023-06-23
	10. HOWARD HUGHES CORP/THE			2023-06-28
	5. CHESAPEAKE UTILITIES CORP			2023-06-29
	26. CRYPORT INC			2023-06-29
	1. AXONICS MODULATION TECHNOLOG		2022-08-12	2023-07-03
	23. AXONICS MODULATION TECHNOLOG			2023-07-03
	36. BRIDGEBIO PHARMA INC			2023-07-03
	19. CALIX NETWORKS INC			2023-07-03
	1. KARUNA THERAPEUTICS INC		2022-04-05	2023-07-03
	23. VIRIDIAN THERAPEUTICS INC			2023-07-03
	60. APPLIED DIGITAL CORPORATION		2023-05-30	2023-07-06
	33. WERNER ENTERPRISES INC		2020-10-16	2023-07-06
	29. BELLRING DISTR LLC COMMON STOCK			2023-07-07
	6. SCORPIO TANKERS INC		2022-12-05	2023-07-07
	16. BWX TECHNOLOGIES INC		2022-07-28	2023-07-12
	7. CLEAN HBRS INC			2023-07-12
	4. CONMED CORP			2023-07-12
	8. HEALTHEQUITY INC			2023-07-12
	14. SCHRODINGER INC			2023-07-12
	1. GRANITE CONSTR CV 2.750% 11/01/24		1911-11-11	2023-07-13
	29. SPS COMMERCE INC		2021-09-29	2023-07-13
	182. SKYWORKS SOLUTIONS INC		2018-10-17	2023-07-13
	17.00018 TG THERAPEUTICS INC			2023-07-13
	14.99982 TG THERAPEUTICS INC		2023-05-02	2023-07-13
	273. WILLIAMS SONOMA INC		2020-05-04	2023-07-13
	24. SCORPIO TANKERS INC			2023-07-13
	39. GREEN PLAINS INC.			2023-07-14
	5. OMNICELL INC COM		2022-08-05	2023-07-14
	5. TRANSMEDICS GROUP INC			2023-07-14
	5. HEALTHEQUITY INC		2022-08-25	2023-07-17
	1. KARUNA THERAPEUTICS INC		2022-04-05	2023-07-17
	17. TG THERAPEUTICS INC			2023-07-17
	5. CHESAPEAKE UTILITIES CORP			2023-07-18
	47. LESLIES INC		2023-01-04	2023-07-18
	83. LESLIES INC			2023-07-18
	23. PORTLAND GENERAL ELECTRIC CO			2023-07-18
	9. PORTLAND GENERAL ELECTRIC CO		2022-04-06	2023-07-18
	3. CHESAPEAKE UTILITIES CORP		2022-03-30	2023-07-19
	2. REATA PHARMACEUTICALS INC		2023-03-01	2023-07-19
	1. CHESAPEAKE UTILITIES CORP		2022-03-30	2023-07-20
	169. AKAMAI TECHNOLOGIES COM		2020-03-24	2023-07-21
	21. ASBURY AUTOMOTIVE GROUP		2021-04-15	2023-07-21
	3. CONMED CORP		2020-10-07	2023-07-21
	6. MA COM TECH SOLUTIONS HLDNGS INC		2023-03-29	2023-07-21
	3. OMNICELL INC COM		2022-08-05	2023-07-21
	6. POWER INTEGRATIONS INC			2023-07-21
	2. SPS COMMERCE INC		2023-06-07	2023-07-21
	2. SILICON LABORATORIES INC			2023-07-21
	4. CHESAPEAKE UTILITIES CORP		2022-11-03	2023-07-24
	1. CHESAPEAKE UTILITIES CORP		2022-03-30	2023-07-24
	25. PIEDMONT LITHIUM INC			2023-07-24
	4. CONMED CORP		2020-10-07	2023-07-25
	5. MA COM TECH SOLUTIONS HLDNGS INC		2021-04-12	2023-07-25
	7917.656 MAINSTAY CBRE GLOBAL INFRASTRUCTURE		2023-02-03	2023-07-25
	11297.147 MAINSTAY CBRE GLOBAL INFRASTRUCTURE		2022-03-02	2023-07-25
	6. CONMED CORP			2023-07-26
	6. MA COM TECH SOLUTIONS HLDNGS INC			2023-07-26
	2. SILICON LABORATORIES INC			2023-07-26
	5. SYNAPTICS INC			2023-07-26
	17. BWX TECHNOLOGIES INC		2022-07-21	2023-07-27
	7. OMNICELL INC COM		2022-11-15	2023-07-27
	4. OMNICELL INC COM			2023-07-27
	28. TEREX CORP			2023-07-27
	15. EXTREME NETWORKS INC COM W/RIGHTS ATTACH		2023-05-31	2023-07-28
	14. REPLIMUNE GROUP INC			2023-07-28
	3. KARUNA THERAPEUTICS INC			2023-07-31
	8. REATA PHARMACEUTICALS INC			2023-07-31
	16. STAG INDUSTRIAL INC			2023-07-31
	10. TERRENO REALTY CORP			2023-07-31
	12. REATA PHARMACEUTICALS INC			2023-08-01
	2. MA COM TECH SOLUTIONS HLDNGS INC		2023-05-30	2023-08-03
	2. MA COM TECH SOLUTIONS HLDNGS INC		2022-06-24	2023-08-03
	4. WALKER & DUNLOP INC		2023-07-13	2023-08-03
	1. LANTHEUS HOLDINGS INC		2022-08-12	2023-08-10
	6. FRANKLIN ELEC INC		2021-05-04	2023-08-11
	17. GREEN PLAINS INC.		2022-09-02	2023-08-11
	5. CHORD ENERGY CORPORATION		2021-06-10	2023-08-15
	119. COPART INC COM		2017-12-11	2023-08-17
	2. GREEN PLAINS INC.		2022-09-02	2023-08-18
	28. GREEN PLAINS INC.		2021-02-17	2023-08-18
	4. ICF INTERNATIONAL INC		2023-03-14	2023-08-18
	46. COLUMBIA BKG SYS INC			2023-08-25
	7. DECKERS OUTDOOR CORP		2022-07-20	2023-08-28
	2. ONTO INNOVATION INC		2023-07-31	2023-08-30
	3. LANTHEUS HOLDINGS INC		2022-08-12	2023-09-01
	15. REPLIMUNE GROUP INC		2022-12-09	2023-09-01
	87. TEGNA INC		2022-12-05	2023-09-01
	1. GRANITE CONSTR CV 2.750% 11/01/24		2023-01-01	2023-09-05
	1. MERIT MEDICAL SYSTEMS INC COM		1911-11-11	2023-09-05
	28. AZEK CO INC CL A			2023-09-08
	3. CACI INTERNATIONAL INC CL A		2022-09-06	2023-09-08
	2. CLEAN HBRS INC		2023-01-25	2023-09-08
	24. COLUMBIA BKG SYS INC			2023-09-08
	8. VISTEON CORP			2023-09-08
	3. VISTEON CORP		2020-10-15	2023-09-08
	5. WINTRUST FINANCIAL CORP		2023-02-07	2023-09-08
	10. WINTRUST FINANCIAL CORP			2023-09-08
	26. ACELYRIN INC COM			2023-09-13
	2. ASBURY AUTOMOTIVE GROUP		2021-04-15	2023-09-14
	25. CHARLES RIV LABORATORIES INTL INC		2017-09-07	2023-09-14
	15. CHURCH AND DWIGHT CO INC		2007-12-28	2023-09-14
	269. FLOOR DECOR HOLDINGS INC A		2020-12-18	2023-09-14
	7. POOL CORPORATION		2017-02-21	2023-09-14
	25. RAYMOND JAMES FINL INC		2013-04-19	2023-09-14
	6. WEST PHARMACEUTICAL SVCS INC		2020-07-02	2023-09-14
	9. ONTO INNOVATION INC			2023-09-18
	9. RAMBUS INC			2023-09-18
	20. REPLIMUNE GROUP INC			2023-09-18
	3. SUPER MICRO COMPUTER INC			2023-09-18
	33. COLUMBIA BKG SYS INC			2023-09-19
	10. GUARDANT HEALTH INC		2023-09-01	2023-09-19
	1. SILICON LABORATORIES INC		2023-03-23	2023-09-19
	1. SYNAPTICS INC		2023-03-23	2023-09-19
	1. SYNAPTICS INC		2022-06-21	2023-09-19
	9. WINTRUST FINANCIAL CORP		2020-06-01	2023-09-21
	63. POINT BIOPHARMA GLOBAL INC			2023-09-22
	5. SIMPSON MFG CO INC			2023-09-22
	7. SYNAPTICS INC			2023-09-22
	26. VIRIDIAN THERAPEUTICS INC			2023-09-22
	30. BRIDGEBIO PHARMA INC			2023-09-26
	30. CYMABAY THERAPEUTICS INC		2023-08-01	2023-09-26
	12. CYTOKINETICS INC		2023-07-28	2023-09-26
	8. CYTOKINETICS INC			2023-09-26
	4. LANTHEUS HOLDINGS INC		2022-10-07	2023-09-26
	13. MORPHIC HOLDING INC			2023-09-26
	3. NOVANTA INC		2023-06-07	2023-09-26
	55. VIKING THERAPEUTICS INC			2023-09-26
	7. PROTHENA CORP PLC			2023-09-26
	42. INDEPENDENCE REALTY TRUST IN			2023-09-27
	23. VIKING THERAPEUTICS INC		2022-12-19	2023-09-27
	39. ALLETE INC		2023-03-20	2023-10-03
	70. INDEPENDENCE REALTY TRUST IN			2023-10-03
	3. MOONLAKE IMMUNOTHERAPEUTICS CLASS A		2023-07-17	2023-10-03
	6. WALKER & DUNLOP INC			2023-10-03
	220. BRANDYWINE REALTY TRUST			2023-10-04
	34. H E EQUIPMENT SERVICES INC		2021-04-05	2023-10-05
	18. INDEPENDENT BK CORP MASS			2023-10-11
	4. KINSALE CAPITAL GROUP INC		2022-09-20	2023-10-11
	5. CONMED CORP		2023-10-11	2023-10-12
	3. NUVALENT INC COM		2023-10-05	2023-10-12
	15. OPTION CARE HEALTH INC		2023-07-28	2023-10-12
	1. OPTION CARE HEALTH INC		2022-09-28	2023-10-12
	1. SPS COMMERCE INC		2023-07-31	2023-10-12
	25. SI BONE INC			2023-10-12
	16. VENTYX BIOSCIENCES INC			2023-10-12
	15. COLUMBIA BKG SYS INC		2023-05-24	2023-10-18
	6. CYTOKINETICS INC		2022-04-29	2023-10-18
	3. MADRIGAL PHARMACEUTICALS INC			2023-10-18
	3. RAMBUS INC		2023-05-18	2023-10-18
	1. ROGERS CORP		2023-03-31	2023-10-18
	15. AAON INC			2023-10-19
	29. FORESTAR GROUP INC			2023-10-19
	1. ROGERS CORP		2023-03-31	2023-10-19
	25. AZEK CO INC CL A		2023-07-12	2023-10-20
	2. NOVANTA INC		2023-03-31	2023-10-20
	2. ROGERS CORP			2023-10-20
	3. WORKIVA INC		2022-09-13	2023-10-20
	67. IMMUNOGEN INC COM			2023-10-23
	116. IDEX CORP		2019-03-22	2023-10-25
	1. SPS COMMERCE INC		2023-07-31	2023-10-25
	3. ROGERS CORP		2023-05-01	2023-10-26
	1. SPS COMMERCE INC		2023-07-31	2023-10-26
	2. ONTO INNOVATION INC		2023-06-08	2023-10-30
	7. RAMBUS INC			2023-10-30
	3. WORKIVA INC		2023-05-22	2023-10-30
	2. NOVANTA INC			2023-11-01
	13. HILTON GRAND VACATIONS			2023-11-03
	38. HILTON GRAND VACATIONS			2023-11-03
	4. KINSALE CAPITAL GROUP INC		2022-09-27	2023-11-03
	28. PBF ENERGY INC CLASS A			2023-11-03
	7. MOONLAKE IMMUNOTHERAPEUTICS CLASS A			2023-11-06
	19. DECKERS OUTDOOR CORP		2022-07-20	2023-11-13
	6. FOX FACTORY HOLDING CORP		2023-01-27	2023-11-13
	9. FOX FACTORY HOLDING CORP			2023-11-13
	31. LIVENT CORP		2022-12-21	2023-11-14
	15. LIVENT CORP			2023-11-14
	20. HELMERICH PAYNE INC			2023-11-16
	1. KINSALE CAPITAL GROUP INC		2022-09-27	2023-11-16
	5. SPS COMMERCE INC			2023-11-16
	86. DIAMOND OFFSHORE DRILLING INC			2023-11-17
	89. SHOALS TECHNOLOGIES GROUP IN CL A			2023-11-17
	1. KINSALE CAPITAL GROUP INC		2023-03-27	2023-11-20
	3. KINSALE CAPITAL GROUP INC		2022-09-27	2023-11-20
	25. BELLRING DISTR LLC COMMON STOCK			2023-11-21
	.8 MURAL ONCOLOGY PUB LTD			2023-11-22
	1. MURAL ONCOLOGY PUB LTD			2023-11-22
	9. ARCBEST CORP			2023-11-27
	22. CREDO TECHNOLOGY GROUP HOLDINGS			2023-11-27
	11. CREDO TECHNOLOGY GROUP HOLDINGS			2023-11-29
	15. CACTUS INC A			2023-12-06
	5. CHORD ENERGY CORPORATION		2021-06-10	2023-12-06
	80. PERMIAN RESOURCES CORP CLASS A			2023-12-06
	7. CYTOKINETICS INC			2023-12-11
	58. IMMUNOGEN INC COM			2023-12-13
	9. BWX TECHNOLOGIES INC			2023-12-15
	3. CYTOKINETICS INC		2021-07-20	2023-12-15
	8. CYTOKINETICS INC		2022-07-01	2023-12-15
	9. HEALTHEQUITY INC			2023-12-15
	9. ICF INTERNATIONAL INC			2023-12-15
	4. CLEAN HBRS INC		2022-12-08	2023-12-18
	14. HEALTHEQUITY INC			2023-12-18
	7. LANTHEUS HOLDINGS INC			2023-12-18
	10. PROTHENA CORP PLC		2022-12-16	2023-12-18
	10. BWX TECHNOLOGIES INC		2022-07-21	2023-12-20
	3. CACI INTERNATIONAL INC CL A		2022-09-20	2023-12-20
	3. CLEAN HBRS INC		2022-12-08	2023-12-20
	3. CLEAN HBRS INC		2022-12-08	2023-12-20
	28. CRINETICS PHARMACEUTICALS IN			2023-12-20
	9. CYMABAY THERAPEUTICS INC			2023-12-20
	8. CYMABAY THERAPEUTICS INC		2023-07-05	2023-12-20
	8. CYTOKINETICS INC		2021-07-20	2023-12-20
	7. HEALTHEQUITY INC			2023-12-20
	2. HEALTHEQUITY INC		2022-08-25	2023-12-20
	9. VAXCYTE INC COM			2023-12-20
	6. VAXCYTE INC COM			2023-12-20
	62. IMMATICS N V			2023-12-20
	8. HEALTHEQUITY INC		2022-08-25	2023-12-21
	9. ROCKET PHARMACEUTICALS INC		2023-09-13	2023-12-21
	4. COHEN STEERS INC		2021-02-25	2023-12-22
	10. E L F BEAUTY INC			2023-12-22
	5. EVERCORE INC		2022-11-15	2023-12-22
	3. WALKER & DUNLOP INC		2023-12-07	2023-12-22
	120. ASBURY AUTOMOTIVE GROUP		2021-04-15	2023-12-26
	15. CHOICE HOTELS INTL INC		2023-04-12	2023-12-26
	189. CHOICE HOTELS INTL INC		2022-10-14	2023-12-26
	385. CIENA CORPORATION NEW		2020-01-31	2023-12-26
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P
	CAPITAL GAIN DIVIDENDS	P

(e) Gross sales price		(g) Cost or other basis plus expense of sale	(h) Gain or (loss) (e) plus (f) minus (g)
a	1,194	1,174	20
b	615	571	44
c	336	398	-62
d	516	523	-7
e	289	287	2
	296	343	-47
	911	1,081	-170
	300	184	116
	657	618	39
	288	463	-175
	215	200	15
	190	296	-106
	390	313	77
	191	247	-56
	116	114	2
	1,783	1,744	39
	286	261	25
	1,943	1,546	397
	195	247	-52
	247	243	4
	869	553	316
	15	14	1
	403	453	-50
	253	224	29
	219	429	-210
	455	379	76
	14	14
	116	147	-31
	291	369	-78
	1,036	1,383	-347
	157	92	65
	32	39	-7
	959	1,252	-293
	165	131	34
	346	533	-187
	22	46	-24
	328	290	38
	326	535	-209
	866	1,116	-250
	1,111	810	301
	531	573	-42
	13	14	-1
	1,973	1,945	28
	414	453	-39
	507	560	-53
	40,114	20,561	19,553
	492	702	-210
	934	798	136
	650	370	280
	608	678	-70
	748	827	-79
	528	741	-213
	719	1,458	-739
	1,037	632	405
	896	998	-102
	636	516	120
	286	332	-46
	728	723	5
	38		38
	231	189	42
	313	247	66
	296	215	81
	273	245	28
	475	371	104
	447	577	-130
	388	357	31
	173	111	62
	672	1,250	-578
	501	516	-15
	17,279	11,659	5,620
	335	442	-107
	473	524	-51
	922	705	217
	2,716	1,833	883
	25		25
	434	347	87
	6,579	16,535	-9,956
	175	227	-52
	284	348	-64
	502	546	-44
	580	736	-156
	11,313	4,847	6,466
	1,503	1,559	-56
	732	654	78
	917	1,068	-151
	715	884	-169
	17,219	2,778	14,441
	591	655	-64
	1,034	1,146	-112
	797	792	5
	488	421	67
	450	568	-118
	303	379	-76
	1,248	1,339	-91
	127	99	28
	620	900	-280
	917	1,074	-157
	3,634	2,624	1,010
	416	380	36
	1,289	788	501
	1,828	966	862
	11,774	3,382	8,392
	6,448	4,105	2,343
	8,877	3,163	5,714
	965	566	399
	419	445	-26
	745	698	47
	23,434	25,996	-2,562
	19,311	28,889	-9,578
	330	427	-97
	547	729	-182
	669	357	312
	282	254	28
	686	582	104
	437	299	138
	442	698	-256
	428	682	-254
	458	480	-22
	484	512	-28
	264	374	-110
	725	440	285
	1,038	794	244
	943	1,826	-883
	512	601	-89
	2,009	1,762	247
	547	499	48
	601	752	-151
	299	250	49
	182	63	119
	860	871	-11
	246	189	57
	253	284	-31
	812	744	68
	2,527	2,047	480
	650	1,175	-525
	547	658	-111
	633	706	-73
	867	542	325
	434	264	170
	562	340	222
	577	329	248
	950	567	383
	212	280	-68
	477	732	-255
	570	530	40
	285	164	121
	539	647	-108
	583	734	-151
	1,898	1,947	-49
	1,671	1,686	-15
	1,896	1,676	220
	88	104	-16
	881	1,316	-435
	15,284	21,085	-5,801
	4,082	3,721	361
	2,638	2,836	-198
	773	938	-165
	593	698	-105
	447	1,170	-723
	51	72	-21
	1,164	1,391	-227
	633	595	38
	940	1,323	-383
	216	138	78
	554	799	-245
	462	551	-89
	1,432	1,419	13
	1,015	699	316
	272	320	-48
	1,132	892	240
	1,168	933	235
	539	510	29
	518	525	-7
	766	578	188
	44		44
	5,482	4,748	734
	20,785	15,990	4,795
	370	528	-158
	326	469	-143
	35,501	17,117	18,384
	1,066	1,276	-210
	1,260	1,447	-187
	362	545	-183
	461	313	148
	308	313	-5
	211	138	73
	363	593	-230
	594	693	-99
	263	588	-325
	464	2,148	-1,684
	1,059	1,181	-122
	414	512	-98
	363	416	-53
	226	181	45
	123	139	-16
	15,640	14,945	695
	5,026	4,485	541
	367	252	115
	393	419	-26
	189	327	-138
	554	500	54
	362	335	27
	316	355	-39
	485	439	46
	121	139	-18
	1,321	1,468	-147
	481	336	145
	340	290	50
	98,812	100,000	-1,188
	140,988	146,524	-5,536
	733	500	233
	406	295	111
	291	347	-56
	446	661	-215
	1,158	938	220
	435	390	45
	248	387	-139
	1,600	1,266	334
	408	315	93
	283	375	-92
	599	407	192
	1,325	724	601
	579	563	16
	592	653	-61
	1,996	1,053	943
	149	121	28
	149	95	54
	348	358	-10
	68	105	-37
	573	518	55
	560	612	-52
	763	447	316
	10,386	2,613	7,773
	63	72	-9
	888	723	165
	501	440	61
	909	1,032	-123
	3,626	2,052	1,574
	273	248	25
	202	315	-113
	295	376	-81
	1,356	1,746	-390
	809		809
	79		79
	913	1,041	-128
	951	826	125
	331	259	72
	486	532	-46
	1,099	1,219	-120
	412	258	154
	377	473	-96
	754	522	232
	261	612	-351
	466	427	39
	5,178	2,718	2,460
	1,431	205	1,226
	25,576	26,879	-1,303
	2,468	815	1,653
	2,700	733	1,967
	2,383	1,361	1,022
	1,121	1,052	69
	497	564	-67
	357	483	-126
	728	779	-51
	667	702	-35
	278	341	-63
	117	171	-54
	84	109	-25
	84	122	-38
	673	385	288
	440	675	-235
	734	625	109
	578	681	-103
	402	702	-300
	835	1,035	-200
	449	387	62
	364	399	-35
	243	323	-80
	261	266	-5
	295	630	-335
	421	511	-90
	650	1,019	-369
	328	422	-94
	596	770	-174
	254	159	95
	1,963	2,512	-549
	947	1,195	-248
	172	172
	415	536	-121
	851	1,100	-249
	1,373	1,304	69
	875	1,085	-210
	1,754	1,020	734
	455	488	-33
	179	176	3
	467	513	-46
	31	32	-1
	168	181	-13
	431	690	-259
	310	507	-197
	299	314	-15
	206	242	-36
	407	806	-399
	174	175	-1
	127	163	-36
	796	558	238
	660	677	-17
	124	163	-39
	645	771	-126
	271	315	-44
	249	323	-74
	296	209	87
	852	1,174	-322
	21,838	17,531	4,307
	156	181	-25
	357	480	-123
	157	181	-24
	226	225	1
	349	379	-30
	278	289	-11
	264	304	-40
	483	578	-95
	1,411	1,772	-361
	1,356	973	383
	1,282	1,522	-240
	276	400	-124
	11,903	5,571	6,332
	338	694	-356
	507	848	-341
	434	649	-215
	210	354	-144
	739	918	-179
	352	243	109
	884	897	-13
	1,065	1,368	-303
	1,304	1,851	-547
	354	293	61
	1,063	730	333
	1,224	594	630
	3	10	-7
	4	12	-8
	1,075	1,040	35
	422	356	66
	209	176	33
	606	597	9
	776	447	329
	1,001	1,057	-56
	248	282	-34
	1,723	744	979
	695	498	197
	108	86	22
	289	322	-33
	568	664	-96
	1,209	982	227
	704	473	231
	889	1,011	-122
	394	587	-193
	365	587	-222
	765	552	213
	950	846	104
	532	355	177
	530	355	175
	1,021	767	254
	201	112	89
	177	96	81
	293	229	64
	448	492	-44
	128	125	3
	546	446	100
	360	295	65
	588	584	4
	522	501	21
	254	189	65
	298	256	42
	1,404	1,118	286
	848	582	266
	321	276	45
	26,959	25,627	1,332
	1,702	1,815	-113
	21,451	22,894	-1,443
	16,994	15,769	1,225
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613
			78,613

Complete only for assets showing gain in column (h) and owned by the foundation on 12/31/69			(l) Gains (Col. (h) gain minus col. (k), but not less than -0-) or Losses (from col.(h))
(i) F.M.V. as of 12/31/69	(j) Adjusted basis as of 12/31/69	(k) Excess of col. (i) over col. (j), if any
a			20
b			44
c			-62
d			-7
e			2
			-47
			-170
			116
			39
			-175
			15
			-106
			77
			-56
			2
			39
			25
			397
			-52
			4
			316
			1
			-50
			29
			-210
			76

			-31
			-78
			-347
			65
			-7
			-293
			34
			-187
			-24
			38
			-209
			-250
			301
			-42
			-1
			28
			-39
			-53
			19,553
			-210
			136
			280
			-70
			-79
			-213
			-739
			405
			-102
			120
			-46
			5
			38
			42
			66
			81
			28
			104
			-130
			31
			62
			-578
			-15
			5,620
			-107
			-51
			217
			883
			25
			87
			-9,956
			-52
			-64
			-44
			-156
			6,466
			-56
			78
			-151
			-169
			14,441
			-64
			-112
			5
			67
			-118
			-76
			-91
			28
			-280
			-157
			1,010
			36
			501
			862
			8,392
			2,343
			5,714
			399
			-26
			47
			-2,562
			-9,578
			-97
			-182
			312
			28
			104
			138
			-256
			-254
			-22
			-28
			-110
			285
			244
			-883
			-89
			247
			48
			-151
			49
			119
			-11
			57
			-31
			68
			480
			-525
			-111
			-73
			325
			170
			222
			248
			383
			-68
			-255
			40
			121
			-108
			-151
			-49
			-15
			220
			-16
			-435
			-5,801
			361
			-198
			-165
			-105
			-723
			-21
			-227
			38
			-383
			78
			-245
			-89
			13
			316
			-48
			240
			235
			29
			-7
			188
			44
			734
			4,795
			-158
			-143
			18,384
			-210
			-187
			-183
			148
			-5
			73
			-230
			-99
			-325
			-1,684
			-122
			-98
			-53
			45
			-16
			695
			541
			115
			-26
			-138
			54
			27
			-39
			46
			-18
			-147
			145
			50
			-1,188
			-5,536
			233
			111
			-56
			-215
			220
			45
			-139
			334
			93
			-92
			192
			601
			16
			-61
			943
			28
			54
			-10
			-37
			55
			-52
			316
			7,773
			-9
			165
			61
			-123
			1,574
			25
			-113
			-81
			-390
			809
			79
			-128
			125
			72
			-46
			-120
			154
			-96
			232
			-351
			39
			2,460
			1,226
			-1,303
			1,653
			1,967
			1,022
			69
			-67
			-126
			-51
			-35
			-63
			-54
			-25
			-38
			288
			-235
			109
			-103
			-300
			-200
			62
			-35
			-80
			-5
			-335
			-90
			-369
			-94
			-174
			95
			-549
			-248

			-121
			-249
			69
			-210
			734
			-33
			3
			-46
			-1
			-13
			-259
			-197
			-15
			-36
			-399
			-1
			-36
			238
			-17
			-39
			-126
			-44
			-74
			87
			-322
			4,307
			-25
			-123
			-24
			1
			-30
			-11
			-40
			-95
			-361
			383
			-240
			-124
			6,332
			-356
			-341
			-215
			-144
			-179
			109
			-13
			-303
			-547
			61
			333
			630
			-7
			-8
			35
			66
			33
			9
			329
			-56
			-34
			979
			197
			22
			-33
			-96
			227
			231
			-122
			-193
			-222
			213
			104
			177
			175
			254
			89
			81
			64
			-44
			3
			100
			65
			4
			21
			65
			42
			286
			266
			45
			1,332
			-113
			-1,443
			1,225

2	Capital gain net income or (net capital loss)	If gain, also enter in Part I, line 7 If (loss), enter -0- in Part I, line 7	2	157,928
3	Net short-term capital gain or (loss) as defined in sections 1222(5) and (6):
	If gain, also enter in Part I, line 8, column (c) (see instructions). If (loss), enter -0- in Part I, line 8 ...................		3

Part V

Excise Tax Based on Investment Income (Section 4940(a), 4940(b), 4940(e), or 4948—see instructions)

1a	Exempt operating foundations described in section 4940(d)(2), check here and enter “N/A" on line 1.
	Date of ruling or determination letter: (attach copy of letter if necessary–see instructions)	1	5,694
b	All other domestic foundations enter 1.39% (0.0139) of line 27b. Exempt foreign organizations enter 4% (0.04) of Part I, line 12, col. (b)
2	Tax under section 511 (domestic section 4947(a)(1) trusts and taxable foundations only. Others enter -0-)	2	0
3	Add lines 1 and 2...........................	3	5,694
4	Subtitle A (income) tax (domestic section 4947(a)(1) trusts and taxable foundations only. Others enter -0-)	4	0
5	Tax based on investment income. Subtract line 4 from line 3. If zero or less, enter -0- .....	5	5,694
6	Credits/Payments:

a	2023 estimated tax payments and 2022 overpayment credited to 2023	6a	5,200
b	Exempt foreign organizations—tax withheld at source......	6b	0
c	Tax paid with application for extension of time to file (Form 8868)...	6c	495
d	Backup withholding erroneously withheld ..........	6d

7	Total credits and payments. Add lines 6a through 6d..............		7	5,695
8	Enter any penalty for underpayment of estimated tax. Check here if Form 2220 is attached.		8	0
9	Tax due. If the total of lines 5 and 8 is more than line 7, enter amount owed.......		9
10	Overpayment. If line 7 is more than the total of lines 5 and 8, enter the amount overpaid...		10	1
11	Enter the amount of line 10 to be: Credited to 2024 estimated tax1	Refunded	11	0

Form 990-PF (2023)

Page 4

Part VI-A

Statements Regarding Activities

During the tax year, did the foundation attempt to influence any national, state, or local legislation or did

Yes

it participate or intervene in any political campaign? ....................

Did it spend more than $100 during the year (either directly or indirectly) for political purposes? See the instructions

for the definition.................................

If the answer is "Yes" to 1a or 1b, attach a detailed description of the activities and copies of any materials

published or distributed by the foundation in connection with the activities.

Did the foundation file Form 1120-POL for this year?.....................

Enter the amount (if any) of tax on political expenditures (section 4955) imposed during the year:

(1) On the foundation. right arrow

$ (2) On foundation managers. right arrow

Enter the reimbursement (if any) paid by the foundation during the year for political expenditure tax imposed

on foundation managers. right arrow

Has the foundation engaged in any activities that have not previously been reported to the IRS?.......

If "Yes," attach a detailed description of the activities.

Has the foundation made any changes, not previously reported to the IRS, in its governing instrument, articles

of incorporation, or bylaws, or other similar instruments? If "Yes," attach a conformed copy of the changes....

Did the foundation have unrelated business gross income of $1,000 or more during the year?.........

If "Yes," has it filed a tax return on Form 990-T for this year?...................

Was there a liquidation, termination, dissolution, or substantial contraction during the year?.........

If "Yes," attach the statement required by General Instruction T.

Are the requirements of section 508(e) (relating to sections 4941 through 4945) satisfied either:

By language in the governing instrument, or

By state legislation that effectively amends the governing instrument so that no mandatory directions

that conflict with the state law remain in the governing instrument? ................

Yes

Did the foundation have at least $5,000 in assets at any time during the year? If "Yes," complete Part II, col. (c),

and Part XIV..................................

Yes

Enter the states to which the foundation reports or with which it is registered (see instructions)

If the answer is "Yes" to line 7, has the foundation furnished a copy of Form 990-PF to the Attorney

General (or designate) of each state as required by General Instruction G? If "No," attach explanation .

Yes

Is the foundation claiming status as a private operating foundation within the meaning of section 4942(j)(3)

or 4942(j)(5) for calendar year 2023 or the taxable year beginning in 2023? See the instructions for Part XIII.

If "Yes," complete Part XIII .............................

Did any persons become substantial contributors during the tax year? If "Yes," attach a schedule listing their names

and addresses. ...............................

At any time during the year, did the foundation, directly or indirectly, own a controlled entity within the

meaning of section 512(b)(13)? If "Yes," attach schedule. See instructions .............

Did the foundation make a distribution to a donor advised fund over which the foundation or a disqualified person had

advisory privileges? If "Yes," attach statement. See instructions.................

Did the foundation comply with the public inspection requirements for its annual returns and exemption application?

Yes

Website address right arrow

The books are in care of right arrow

U S BANK NATIONAL ASSOCIATION Telephone no. right arrow

(855) 452-4057

Located at right arrow

101 EAST 5TH STREETST PAULMN ZIP+4 right arrow

55101

Section 4947(a)(1) nonexempt charitable trusts filing Form 990-PF in lieu of Form 1041 —check here ......... right arrow

and enter the amount of tax-exempt interest received or accrued during the year ........ right arrow

16 At any time during calendar year 2023, did the foundation have an interest in or a signature or other authority over YesNo

a bank, securities, or other financial account in a foreign country? .................

16 No

See the instructions for exceptions and filing requirements for FinCEN Form 114. If "Yes", enter the name of the foreign
country right arrow

Form 990-PF (2023)

Page 5

Part VI-B

Statements Regarding Activities for Which Form 4720 May Be Required

File Form 4720 if any item is checked in the "Yes" column, unless an exception applies.

Yes

During the year did the foundation (either directly or indirectly):

(1) Engage in the sale or exchange, or leasing of property with a disqualified person? ...........

1a(1)

(2) Borrow money from, lend money to, or otherwise extend credit to (or accept it from)

a disqualified person? ..............................

1a(2)

(3) Furnish goods, services, or facilities to (or accept them from) a disqualified person? ...........

1a(3)

(4) Pay compensation to, or pay or reimburse the expenses of, a disqualified person? ............

1a(4)

Yes

(5) Transfer any income or assets to a disqualified person (or make any of either available

for the benefit or use of a disqualified person)? ......................

1a(5)

(6) Agree to pay money or property to a government official? (Exception. Check "No"

if the foundation agreed to make a grant to or to employ the official for a period

after termination of government service, if terminating within 90 days.) ...............

1a(6)

If any answer is "Yes" to 1a(1)–(6), did any of the acts fail to qualify under the exceptions described in Regulations

section 53.4941(d)-3 or in a current notice regarding disaster assistance? See instructions ..........

Organizations relying on a current notice regarding disaster assistance check here ........ right arrow

Did the foundation engage in a prior year in any of the acts described in 1a, other than excepted acts,

that were not corrected before the first day of the tax year beginning in 2023? .............

Taxes on failure to distribute income (section 4942) (does not apply for years the foundation was a private

operating foundation defined in section 4942(j)(3) or 4942(j)(5)):

At the end of tax year 2023, did the foundation have any undistributed income (Part XII, lines 6d

and 6e) for tax year(s) beginning before 2023?....................

If "Yes," list the years right arrow

20, 20, 20, 20

Are there any years listed in 2a for which the foundation is not applying the provisions of section 4942(a)(2)

(relating to incorrect valuation of assets) to the year’s undistributed income? (If applying section 4942(a)(2)

to all years listed, answer "No" and attach statement—see instructions.) ..............

If the provisions of section 4942(a)(2) are being applied to any of the years listed in 2a, list the years here.

20, 20, 20, 20

Did the foundation hold more than a 2% direct or indirect interest in any business enterprise at

any time during the year? ..............................

If "Yes," did it have excess business holdings in 2023 as a result of (1) any purchase by the foundation

or disqualified persons after May 26, 1969; (2) the lapse of the 5-year period (or longer period approved

by the Commissioner under section 4943(c)(7)) to dispose of holdings acquired by gift or bequest; or (3)

the lapse of the 10-, 15-, or 20-year first phase holding period? (Use Schedule C, Form 4720, to determine

if the foundation had excess business holdings in 2023.) .....................

Did the foundation invest during the year any amount in a manner that would jeopardize its charitable purposes?

Did the foundation make any investment in a prior year (but after December 31, 1969) that could jeopardize its

charitable purpose that had not been removed from jeopardy before the first day of the tax year beginning in 2023? ..

Form 990-PF (2023)

Page 6

Part VI-B

Statements Regarding Activities for Which Form 4720 May Be Required (continued)

During the year did the foundation pay or incur any amount to:

Yes

(1) Carry on propaganda, or otherwise attempt to influence legislation (section 4945(e))? ..........

5a(1)

(2) Influence the outcome of any specific public election (see section 4955); or to carry

on, directly or indirectly, any voter registration drive? ....................

5a(2)

(3) Provide a grant to an individual for travel, study, or other similar purposes? .............

5a(3)

(4) Provide a grant to an organization other than a charitable, etc., organization described

in section 4945(d)(4)(A)? See instructions ........................

5a(4)

(5) Provide for any purpose other than religious, charitable, scientific, literary, or

educational purposes, or for the prevention of cruelty to children or animals? .............

5a(5)

If any answer is "Yes" to 5a(1)–(5), did any of the transactions fail to qualify under the exceptions described in

Regulations section 53.4945 or in a current notice regarding disaster assistance? See instructions ........

Organizations relying on a current notice regarding disaster assistance check ......... right arrow

If the answer is "Yes" to question 5a(4), does the foundation claim exemption from the

tax because it maintained expenditure responsibility for the grant? .................

If "Yes," attach the statement required by Regulations section 53.4945–5(d).

Did the foundation, during the year, receive any funds, directly or indirectly, to pay premiums on

a personal benefit contract? .............................

Did the foundation, during the year, pay premiums, directly or indirectly, on a personal benefit contract? ....

If "Yes" to 6b, file Form 8870.

At any time during the tax year, was the foundation a party to a prohibited tax shelter transaction?

If "Yes", did the foundation receive any proceeds or have any net income attributable to the transaction? .....

Is the foundation subject to the section 4960 tax on payment(s) of more than $1,000,000 in remuneration or

excess parachute payment during the year? .........................

Part VII

Information About Officers, Directors, Trustees, Foundation Managers, Highly Paid Employees,
and Contractors

1 List all officers, directors, trustees, foundation managers and their compensation. See instructions

(a) Name and address	(b) Title, and average hours per week devoted to position	(c) Compensation (If not paid, enter -0-)	(d) Contributions to employee benefit plans and deferred compensation	(e) Expense account, other allowances
US BANK NATIOANAL ASSOC	CORPORATE TRUSTEE 1	113,530
101 EAST 5TH STREET ST PAUL,MN55101	CORPORATE TRUSTEE 1	113,530

2 Compensation of five highest-paid employees (other than those included on line 1—see instructions). If none, enter “NONE."


(a) Name and address of each employee paid more than $50,000	(b) Title, and average hours per week devoted to position	(c) Compensation	(d) Contributions to employee benefit plans and deferred compensation	(e) Expense account, other allowances
NONE









Total number of other employees paid over $50,000...................				0

Form 990-PF (2023)

Page 7

Part VII

Information About Officers, Directors, Trustees, Foundation Managers, Highly Paid Employees,
and Contractors (continued)

3 Five highest-paid independent contractors for professional services (see instructions). If none, enter "NONE".
(a) Name and address of each person paid more than $50,000	(b) Type of service	(c) Compensation
NONE

Total number of others receiving over $50,000 for professional services............. right arrow

Part VIII-A

Summary of Direct Charitable Activities

List the foundation’s four largest direct charitable activities during the tax year. Include relevant statistical information such as the number of organizations and other beneficiaries served, conferences convened, research papers produced, etc.	Expenses
1


2


3


4

Part VIII-B

Summary of Program-Related Investments (see instructions)

Describe the two largest program-related investments made by the foundation during the tax year on lines 1 and 2.	Amount
1


2


All other program-related investments. See instructions.
3

Total. Add lines 1 through 3......................... right arrow

Form 990-PF (2023)

Page 8

Part IX

Minimum Investment Return (All domestic foundations must complete this part. Foreign foundations, see instructions.)

Fair market value of assets not used (or held for use) directly in carrying out charitable, etc.,

purposes:

Average monthly fair market value of securities...................

12,467,946

Average of monthly cash balances.......................

842,549

Fair market value of all other assets (see instructions)................

Total (add lines 1a, b, and c).........................

13,310,495

Reduction claimed for blockage or other factors reported on lines 1a and

1c (attach detailed explanation) .............

Acquisition indebtedness applicable to line 1 assets..................

Subtract line 2 from line 1d.........................

13,310,495

Cash deemed held for charitable activities. Enter 1.5% (0.015) of line 3 (for greater amount, see

instructions) .............................

199,657

Net value of noncharitable-use assets. Subtract line 4 from line 3. ............

13,110,838

Minimum investment return. Enter 5% (0.05) of line 5................

655,542

Part X

Distributable Amount (see instructions) (Section 4942(j)(3) and (j)(5) private operating foundations and certain foreign organizations check here right arrow

and do not complete this part.)

Minimum investment return from Part IX, line 6..................

655,542

Tax on investment income for 2022 from Part V, line 5.......

5,694

Income tax for 2022. (This does not include the tax from Part V.) ...

Add lines 2a and 2b............................

5,694

Distributable amount before adjustments. Subtract line 2c from line 1............

649,848

Recoveries of amounts treated as qualifying distributions................

Add lines 3 and 4............................

649,848

Deduction from distributable amount (see instructions).................

Distributable amount as adjusted. Subtract line 6 from line 5. Enter here and on Part XII, line 1 ...

649,848

Part XI

Qualifying Distributions (see instructions)

Amounts paid (including administrative expenses) to accomplish charitable, etc., purposes:

Expenses, contributions, gifts, etc.—total from Part I, column (d), line 26 ..........

678,293

Program-related investments—total from Part VIII-B..................

Amounts paid to acquire assets used (or held for use) directly in carrying out charitable, etc.,

purposes...............................

Amounts set aside for specific charitable projects that satisfy the:

Suitability test (prior IRS approval required)....................

Cash distribution test (attach the required schedule) .................

Qualifying distributions. Add lines 1a through 3b. Enter here and on Part XII, line 4. .......

678,293

Form 990-PF (2023)

Page 9

Part XII

Undistributed Income (see instructions)

		(a) Corpus	(b) Years prior to 2022	(c) 2022	(d) 2023
1 Distributable amount for 2023 from Part X, line 7					649,848
2 Undistributed income, if any, as of the end of 2022:
a Enter amount for 2022 only.......				0
b Total for prior years:20 , 20, 20			0
3 Excess distributions carryover, if any, to 2022:
a From 2018......	0
b From 2019......	0
c From 2020......	12,840
d From 2021......	0
e From 2022......	91,410
f Total of lines 3a through e ........		104,250
4Qualifying distributions for 2023 from Part
XI, line 4: $ 678,293
a Applied to 2022, but not more than line 2a				0
b Applied to undistributed income of prior years (Election required—see instructions).....			0
c Treated as distributions out of corpus (Election required—see instructions)........		0
d Applied to 2023 distributable amount.....					649,848
e Remaining amount distributed out of corpus		28,445
5 Excess distributions carryover applied to 2023.		0			0
(If an amount appears in column (d), the same amount must be shown in column (a).)
6Enter the net total of each column as indicated below:
a Corpus. Add lines 3f, 4c, and 4e. Subtract line 5		132,695
b Prior years’ undistributed income. Subtract line 4b from line 2b ..........			0
c Enter the amount of prior years’ undistributed income for which a notice of deficiency has been issued, or on which the section 4942(a) tax has been previously assessed......			0
d Subtract line 6c from line 6b. Taxable amount —see instructions ...........			0
e Undistributed income for 2022. Subtract line 4a from line 2a. Taxable amount—see instructions .............				0
f Undistributed income for 2023. Subtract lines 4d and 5 from line 1. This amount must be distributed in 2024 ..........					0
7 Amounts treated as distributions out of corpus to satisfy requirements imposed by section 170(b)(1)(F) or 4942(g)(3) (Election may be required - see instructions) .......		0
8 Excess distributions carryover from 2018 not applied on line 5 or line 7 (see instructions) ...		0
9 Excess distributions carryover to 2024. Subtract lines 7 and 8 from line 6a ......		132,695
10 Analysis of line 9:
a Excess from 2019....	0
b Excess from 2020....	12,840
c Excess from 2021....	0
d Excess from 2022....	91,410
e Excess from 2023....	28,445

Form 990-PF (2023)

Page 10

Part XIII

Private Operating Foundations (see instructions and Part VI-A, question 9)

1a If the foundation has received a ruling or determination letter that it is a private operating
foundation, and the ruling is effective for 2023, enter the date of the ruling ...... right arrow

b Check box to indicate whether the organization is a private operating foundation described in section 4942(j)(3) or4942(j)(5)

2a Enter the lesser of the adjusted net income from Part I or the minimum investment return from Part IX for each year listed ..........	Tax year	Prior 3 years			(e) Total
	(a) 2023	(b) 2022	(c) 2021	(d) 2020	(e) Total

b 85% (0.85) of line 2a .........
c Qualifying distributions from Part XI, line 4 for each year listed .....
d Amounts included in line 2c not used directly for active conduct of exempt activities ..........
e Qualifying distributions made directly for active conduct of exempt activities. Subtract line 2d from line 2c ....
3 Complete 3a, b, or c for the alternative test relied upon:
a “Assets" alternative test—enter:
(1) Value of all assets ......
(2) Value of assets qualifying under section 4942(j)(3)(B)(i)
b “Endowment" alternative test— enter 2/3 of minimum investment return shown in Part IX, line 6 for each year listed ..
c “Support" alternative test—enter:
(1) Total support other than gross investment income (interest, dividends, rents, payments on securities loans (section 512(a)(5)), or royalties) ....
(2) Support from general public and 5 or more exempt organizations as provided in section 4942(j)(3)(B)(iii)....
(3) Largest amount of support from an exempt organization
(4) Gross investment income

Part XIV

Supplementary Information (Complete this part only if the foundation had $5,000 or more in
assets at any time during the year—see instructions.)

1Information Regarding Foundation Managers:

aList any managers of the foundation who have contributed more than 2% of the total contributions received by the foundation
before the close of any tax year (but only if they have contributed more than $5,000). (See section 507(d)(2).)

NONE

bList any managers of the foundation who own 10% or more of the stock of a corporation (or an equally large portion of the
ownership of a partnership or other entity) of which the foundation has a 10% or greater interest.

NONE

2Information Regarding Contribution, Grant, Gift, Loan, Scholarship, etc., Programs:

Check here right arrow

if the foundation only makes contributions to preselected charitable organizations and does not accept
unsolicited requests for funds. If the foundation makes gifts, grants, etc. to individuals or organizations under
other conditions, complete items 2a, b, c, and d. See instructions

aThe name, address, and telephone number or email address of the person to whom applications should be addressed:

bThe form in which applications should be submitted and information and materials they should include:

cAny submission deadlines:

dAny restrictions or limitations on awards, such as by geographical areas, charitable fields, kinds of institutions, or other
factors:

Form 990-PF (2023)

Page 11

Part XIV

Supplementary Information (continued)

3 Grants and Contributions Paid During the Year or Approved for Future Payment
Recipient	If recipient is an individual, show any relationship to any foundation manager or substantial contributor	Foundation status of recipient	Purpose of grant or contribution	Amount
Name and address (home or business)		Foundation status of recipient	Purpose of grant or contribution	Amount
aPaid during the year
COURAGE KENNY FOUNDATION 3915 GOLDEN VALLEY ROAD MINNEAPOLIS,MN55422	NONE	PC	GENERAL OPERATING	64,400
SCIENCE MUSEUM OF MINNESOTA 120 KELLOGG BLVD W SAINT PAUL,MN551021202	NONE	PC	GENERAL OPERATING	64,400
WOLF RIDGE ENVIRONMENTAL 6282 CRANBERRY ROAD FINLAND,MN55603	NONE	PC	GENERAL OPERATING	59,000
GREAT RIVER GREENING 251 STARKEY ST STE 2200 SAINT PAUL,MN551071874	NONE	PC	GENERAL OPERATING	35,000
HARTLEY NATURE CENTER 3001 WOODLAND AVE DULUTH,MN558031980	NONE	PC	GENERAL OPERATING	7,000
MINNESOTA ORCHESTRAL ASSOCIATION ATTN EMILY BOIGENZAHN MINNEAPOLIS,MN554032406	NONE	PC	GENERAL OPERATING	32,200
MINNEAPOLIS INSTITUTE OF ART ATTN KRIS DAVIDSON MINNEAPOLIS,MN55404	NONE	PC	GENERAL OPERATING	32,200
TWIN CITIES PBS 172 EAST 4TH STREET SAINT PAUL,MN55101	NONE	PC	GENERAL OPERATING	35,000
LAKE SUPERIOR ZOOLOGICAL SOCIETY 7210 FREMONT STREET DULUTH,MN558070000	NONE	PC	GENERAL OPERATING	4,000
TRUE FRIENDS 10509 108TH ST NW ANNANDALE,MN553022912	NONE	PC	GENERAL OPERATING	25,000
WILDLIFE REHABILITATION CENTER 2530 DALE ST N ROSEVILLE,MN551133502	NONE	PC	GENERAL OPERATING	100,000
THOMAS IRVINE DODGE FOUNDATION 365 MARIE AVE W WEST ST PAUL,MN551183848	NONE	PC	GENERAL OPERATING	50,000
MINNESOTA ZOO FOUNDATION 13000 ZOO BLVD APPLE VALLEY,MN55124	NONE	PC	GENERAL OPERATING	64,400
THE NATURE CONSERVANCY CORPORATE OFFICE ARLINGTON,VA222031606	NONE	PC	GENERAL OPERATING	64,400
BOYS GIRLS CLUB 317 COMINGO AVENUE JOPLIN,MO64801	NONE	PC	GENERAL OPERATING	7,000
Total ................................. 3a				644,000

bApproved for future payment

Total ................................. 3b

Form 990-PF (2023)

Page 12

Part XV-A

Analysis of Income-Producing Activities

Enter gross amounts unless otherwise indicated.	Unrelated business income		Excluded by section 512, 513, or 514		(e) Related or exempt function income (See instructions.)
1Program service revenue:	(a) Business code	(b) Amount	(c) Exclusion code	(d) Amount	(e) Related or exempt function income (See instructions.)
a
b
c
d
e
f
gFees and contracts from government agencies
2 Membership dues and assessments ....
3 Interest on savings and temporary cash investments ...........
4 Dividends and interest from securities ....			14	354,138
5 Net rental income or (loss) from real estate:
aDebt-financed property......
bNot debt-financed property.....
6 Net rental income or (loss) from personal property
7 Other investment income .....
8 Gain or (loss) from sales of assets other than inventory ............			18	157,928
9 Net income or (loss) from special events:
10 Gross profit or (loss) from sales of inventory
11 Other revenue: aOTHER INCOME			1	425
bFED TAX REFUND			1	4,306
cCARLYLE PE ACCESS			1	21,695
d
e
12 Subtotal. Add columns (b), (d), and (e) ..				538,492

13Total. Add line 12, columns (b), (d), and (e)..................

538,492

(See worksheet in line 13 instructions to verify calculations.)

Part XV-B

Relationship of Activities to the Accomplishment of Exempt Purposes

Line No.	Explain below how each activity for which income is reported in column (e) of Part XV-A contributed importantly to the accomplishment of the foundation’s exempt purposes (other than by providing funds for such purposes). (See instructions.)

Form 990-PF (2023)

Page 13

Part XVI

Information Regarding Transfers To and Transactions and Relationships With Noncharitable Exempt Organizations

Did the organization directly or indirectly engage in any of the following with any other organization described in section 501(c) (other than section 501(c)(3) organizations) or in section 527, relating to political organizations?

Yes

Transfers from the reporting foundation to a noncharitable exempt organization of:

(1) Cash...................................

1a(1)

(2) Other assets.................................

1a(2)

Other transactions:

(1) Sales of assets to a noncharitable exempt organization....................

1b(1)

(2) Purchases of assets from a noncharitable exempt organization..................

1b(2)

(3) Rental of facilities, equipment, or other assets.......................

1b(3)

(4) Reimbursement arrangements...........................

1b(4)

(5) Loans or loan guarantees.............................

1b(5)

(6) Performance of services or membership or fundraising solicitations................

1b(6)

Sharing of facilities, equipment, mailing lists, other assets, or paid employees..............

If the answer to any of the above is "Yes," complete the following schedule. Column (b) should always show the fair market value
of the goods, other assets, or services given by the reporting foundation. If the foundation received less than fair market value
in any transaction or sharing arrangement, show in column (d) the value of the goods, other assets, or services received.

(a) Line No.	(b) Amount involved	(c) Name of noncharitable exempt organization	(d) Description of transfers, transactions, and sharing arrangements

Is the foundation directly or indirectly affiliated with, or related to, one or more tax-exempt organizations
described in section 501(c) (other than section 501(c)(3)) or in section 527? ...........Yes No

If "Yes," complete the following schedule.

(a) Name of organization	(b) Type of organization	(c) Description of relationship

Sign Here

Under penalties of perjury, I declare that I have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete. Declaration of preparer (other than taxpayer) is based on all information of which preparer has any knowledge.
				May the IRS discuss this return with the preparer shown below? See instructions. Yes No
	Signature of officer or trustee	Date	Title

Paid Preparer Use Only	Print/Type preparer's name	Preparer's Signature	Date	Check if self- employed	PTIN
	Firm's name				Firm's EIN
	Firm's address				Phone no.

Form 990-PF (2023)

Additional Data

Software ID:
Software Version:

Form 990PF - Special Condition Description:

Special Condition Description

Name of Bond	End of Year Book Value	End of Year Fair Market Value
48133LRG9 JPM 24M MXEF 2X LBR	200,000	217,640
48133MZ52 JPM 24M MXEA 2X LBR	4,000	4,898
78016FPE8 RBC 24M MXEA 2X LBR	300,000	355,500
48133MZ78 JPM 24M MXEF 2X LBR	247,000	293,634

Category/ Item	Listed at Cost or FMV	Book Value	End of Year Fair Market Value
97MSCX7K5 CARLYLE PRIVATE EQUI	AT COST	257,166	269,186
77957Y106 T ROWE PRICE MID CAP	AT COST	759,867	653,527
56063J344 MAINSTAY FLOATING RA	AT COST	703,549	707,825
19765P596 COLUMBIA SMALL CAP G	AT COST	195,000	133,390
56064L298 MAINSTAY CBRE GLOBAL
06828M876 BARON EMERGING MARKE	AT COST	206,216	248,673
07831C103 BELLRING DISTR LLC C
13161T401 CALVERT SHORT DURATI	AT COST	749,156	731,847
922042858 VANGUARD FTSE EMERGI	AT COST	237,531	236,859
77954Q106 T ROWE PRICE BLUE CH	AT COST	45,087	66,699
025083874 AMERICAN CENT ULTRA	AT COST	154,894	276,981
74440B884 PGIM TOTAL RETURN BO	AT COST	1,234,005	1,178,670
412295107 HARDING LOEVNER INTE	AT COST	615,921	687,609
025076878 AMERICAN CENTURY REA	AT COST	141,694	119,472
921910501 VANGUARD INTERNATION	AT COST	600,942	654,110
464288521 ISHARES CORE US REIT	AT COST	239,090	242,133

Description	Beginning of Year - Book Value	End of Year - Book Value	End of Year - Fair Market Value
ACCRUED INTEREST		0	0
000000000 MISCELLANEOUS ENTRY	12,071	14,490	14,490

Description	Revenue and Expenses per Books	Net Investment Income	Disbursements for Charitable Purposes
OTHER MISC EXPENSES	10,915	0	10,915
STATE FILING FEE/TAX	25	0	25
ADR FEES	2	2	0
ADVISORY COMMITTEE FEES	10,500	0	10,500

Category	Amount	Net Investment Income	Adjusted Net Income	Disbursements for Charitable Purposes
FOREIGN TAXES	3,031	3,031		0
FOREIGN TAXES ON NONQUALIFIED	728	728		0

Name of Stock	End of Year Book Value	End of Year Fair Market Value
761152107 RESMED INC	11,058	25,115
655844108 NORFOLK SOUTHN CORP	29,581	208,724
857477103 STATE STR CORP	64,388	109,761
478160104 JOHNSON JOHNSON	41,930	182,289
609839105 MONOLITHIC POWER SYS	4,684	37,216
65339F101 NEXTERA ENERGY INC	34,928	390,194
592688105 METTLER-TOLEDO INTL	7,020	31,537
17275R102 CISCO SYSTEMS INC	95,207	268,312
754730109 RAYMOND JAMES FINL I	6,923	26,314
949746101 WELLS FARGO CO	102,162	268,200
438516106 HONEYWELL INTERNATIO	37,163	205,306
171340102 CHURCH AND DWIGHT CO	4,106	28,463
30231G102 EXXON MOBIL CORP	77,830	276,645
594918104 MICROSOFT CORP	43,259	679,128
216648402 COOPER COS INC	11,981	28,005
291011104 EMERSON ELECTRIC CO	65,371	291,990
G5960L103 MEDTRONIC PLC	229,223	247,140
717081103 PFIZER INC	98,424	108,250
579780206 MCCORMICK CO NON VTG
73278L105 POOL CORPORATION	8,631	30,302
217204106 COPART INC COM	6,916	30,870
159864107 CHARLES RIV LABORATO	13,591	29,550
33616C100 FIRST REPUBLIC BANK
254543101 DIODES INC	12,481	26,330
874054109 TAKE-TWO INTERACTIVE	23,635	28,005
74758T303 QUALYS INC	25,158	45,144
49338L103 KEYSIGHT TECHNOLOGIE	8,642	24,341
83088M102 SKYWORKS SOLUTIONS I
70432V102 PAYCOM SOFTWARE INC	15,681	25,840
00191U102 ASGN INC
45167R104 IDEX CORP
866674104 SUN COMMUNITIES INC	23,693	22,721
453836108 INDEPENDENT BK CORP	3,832	4,014
16115Q308 CHART INDUSTRIES INC	2,895	3,545
11373M107 BROOKLINE BANCORP IN
92839U206 VISTEON CORP	1,422	1,749
35138V102 FOX FACTORY HOLDING
879360105 TELEDYNE TECHNOLOGIE	18,194	26,777
59064R109 MESA LABS INC
199908104 COMFORT SYS USA INC	559	2,057
197236102 COLUMBIA BKG SYS INC	5,563	4,536
88146M101 TERRENO REALTY CORP	4,399	4,638
057665200 BALCHEM CORP	1,395	2,380
207410101 CONMED CORP	1,854	1,971
012348108 ALBANY INTL CORP CL	1,762	2,947
91324P102 UNITED HEALTH GROUP	102,299	250,073
099502106 BOOZ ALLEN HAMILTON	19,013	31,466
G8473T100 STERIS PLC SHS USD	10,882	26,602
05464T104 AXSOME THERAPEUTICS	1,688	2,308
826919102 SILICON LABORATORIES	1,049	1,190
950755108 WERNER ENTERPRISES I
19247A100 COHEN STEERS INC	3,796	4,620
29444U700 EQUINIX INC	153,453	181,213
969904101 WILLIAMS SONOMA INC
G46188101 HORIZON THERAPEUTICS
29362U104 ENTEGRIS INC	23,433	34,388
09239B109 BLACKLINE INC
229050307 CRYPORT INC
93148P102 WALKER & DUNLOP INC	2,568	3,441
29977A105 EVERCORE INC	3,170	4,447
97650W108 WINTRUST FINANCIAL C	2,856	4,452
64125C109 NEUROCRINE BIOSCIENC
171779309 CIENA CORPORATION NE
05550J101 BJS WHOLESALE CLUB H	25,665	22,598
739276103 POWER INTEGRATIONS I	1,110	1,150
87157D109 SYNAPTICS INC
339750101 FLOOR DECOR HOLDINGS
955306105 WEST PHARMACEUTICAL	19,287	29,930
00971T101 AKAMAI TECHNOLOGIES
34417P100 FOCUS FINANCIAL PART
922280102 VARONIS SYSTEMS INC	2,130	2,943
574599106 MASCO CORP
57776J100 MAXLINEAR INC CLASS
043436104 ASBURY AUTOMOTIVE GR	2,379	2,700
44267D107 HOWARD HUGHES CORP/T
03027X100 AMERICAN TOWER CORP	156,583	147,878
75524B104 RBC BEARINGS INC
393222104 GREEN PLAINS INC.
880779103 TEREX CORP
55405Y100 MA COM TECH SOLUTION	830	1,208
127203107 CACTUS INC A	1,296	1,589
404030108 H E EQUIPMENT SERVI
78463M107 SPS COMMERCE INC	32,974	38,768
05478C105 AZEK CO INC CL A	1,123	1,454
43283X105 HILTON GRAND VACATIO	1,728	1,607
553368101 MP MATLS CORP
674215207 CHORD ENERGY CORPORA	1,748	2,493
30063P105 EXACT SCIENCES CORPO	380,339	292,073
56585A102 MARATHON PETROLEUM C	156,770	465,702
27627N105 EASTERN BANKSHARES I
353514102 FRANKLIN ELEC INC	1,295	1,450
86614U100 SUMMIT MATERIALS INC	2,125	3,423
527064109 LESLIES INC
98139A105 WORKIVA INC	1,699	2,031
971378104 WILLSCOT MOBIL MINI	25,767	22,873
23282W605 CYTOKINETICS INC	607	584
44925C103 ICF INTERNATIONAL IN	2,577	3,218
48576A100 KARUNA THERAPEUTICS
68404L201 OPTION CARE HEALTH I	1,961	2,089
000360206 AAON INC
27032D304 EARTHSTONE ENERGY IN
03237H101 AMYLYX PHARMACEUTICA
646025106 NEW JERSEY RESOURCES
227046109 CROCS INC
243537107 DECKERS OUTDOOR CORP	14,366	32,753
205768302 COMSTOCK RESOURCES I
82489T104 SHOCKWAVE MEDICAL IN
67000B104 NOVANTA INC	1,109	1,516
74349U108 PROMETHEUS BIOSCIENC
05605H100 BWX TECHNOLOGIES INC	2,305	3,299
82982T106 SITIME CORP
42226A107 HEALTHEQUITY INC
184496107 CLEAN HBRS INC	1,099	1,571
398433102 GRIFFON CORP
516544103 LANTHEUS HOLDINGS IN
76029N106 REPLIMUNE GROUP INC
029899101 AMERICAN STATES WATE
87901J105 TEGNA INC	1,805	1,484
925050106 VERONA PHARMA PLC A	2,137	3,002
165303108 CHESAPEAKE UTILITIES
580589109 MCGRATH RENTCORP
053611109 AVERY DENNISON CORP	24,977	26,887
09627Y109 BLUEPRINT MEDICINES
169905106 CHOICE HOTELS INTL I
04280A100 ARROWHEAD PHARMACEUT	933	704
49714P108 KINSALE CAPITAL GROU
Y7542C130 SCORPIO TANKERS INC	3,177	3,526
92332V107 VENTYX BIOSCIENCES I
29084Q100 EMCOR GROUP INC	24,927	35,115
423452101 HELMERICH PAYNE INC	1,522	1,413
G72800108 PROTHENA CORP PLC
G037AX101 AMBARELLA INC
28618M106 ELEMENT SOLUTIONS IN	2,542	3,031
30226D106 EXTREME NETWORKS INC	749	670
68213N109 OMNICELL INC COM
13100M509 CALIX NETWORKS INC
761330109 REVANCE THERAPEUTICS
844895102 SOUTHWEST GAS HOLDIN	4,407	4,118
G3682E192 FRONTLINE LTD ORDINA
896239100 TRIMBLE NAV LTD COM
78709Y105 SAIA INC	25,474	39,002
G4388N106 HELEN OF TROY LTD	2,263	2,779
92686J106 VIKING THERAPEUTICS
127190304 CACI INTERNATIONAL I	1,936	2,267
53814L108 LIVENT CORP
00973Y108 AKERO THERAPEUTICS I
05465P101 AXONICS MODULATION T
736508847 PORTLAND GENERAL ELE	2,468	2,124
86333M108 STRIDE INC
92790C104 VIRIDIAN THERAPEUTIC
90384S303 ULTRA SALON COSMETIC	25,403	31,359
775133101 ROGERS CORP	1,675	1,585
007973100 ADVANCED ENERGY INDS	1,669	1,634
01741R102 ALLEGHENY TECHNOLOGI	3,153	3,501
03209R103 AMPHASTAR PHARMACEUT	1,623	1,856
03937C105 ARCBEST CORP	1,674	1,923
047649108 ATKORE INTERNATIONAL	2,185	2,400
05969A105 BANCORP INC DEL	3,167	3,470
07831C103 BELLRING DISTR LLC C	733	1,829
099406100 BOOT BARN HOLDINGS I	1,048	998
10806X102 BRIDGEBIO PHARMA INC	1,177	2,261
115236101 BROWN BROWN INC	20,724	20,977
116794108 BRUKER CORPORATION	29,447	26,379
14888U101 CATALYST PHARMACEUTI	2,459	2,606
15872M104 CHAMPIONX CORPORATIO	32,475	27,896
21044C107 CONSTRUCTION PARTNER	1,943	2,089
224408104 CRANE COMPANY	30,605	39,459
23257D103 CYMABAY THERAPEUTICS	1,396	2,858
237194105 DARDEN RESTAURANTS I	27,391	30,724
25271C201 DIAMOND OFFSHORE DRI	2,511	2,262
25402D102 DIGITALOCEAN HLDGS I	886	1,174
26856L103 E L F BEAUTY INC	1,533	2,165
296315104 E S C O TECHNOLOGIES	1,928	2,107
303075105 FACTSET RESEARCH SYS	26,618	31,962
31188V100 FASTLY INC CLASS A	1,096	1,068
346232101 FORESTAR GROUP INC	2,165	2,778
358054104 FRESHWORKS INC CLASS	1,880	2,185
436440101 HOLOGIC INC	27,196	23,364
498894104 KNIFE RIV HLDG CO	2,810	3,772
513847103 LANCASTER COLONY COR	2,557	2,496
52661A108 RADA ELECTR INDS LTD	3,868	4,389
558868105 MADRIGAL PHARMACEUTI	627	694
59001A102 MERITAGE HOMES CORPO	2,185	2,787
59100U108 PATHWARD FINANCIAL I	3,286	3,282
65290E101 NEXTRACKER INC CLASS	2,449	2,764
683344105 ONTO INNOVATION INC	1,123	1,529
691497309 OXFORD INDS INC	1,011	1,100
69404D108 PACIFIC BIOSCIENCES	1,806	2,158
71375U101 PERFICIENT INC	33,624	23,564
71424F105 PERMIAN RESOURCES CO	2,484	2,897
74366E102 PROTAGONIST THERAPEU	613	688
750917106 RAMBUS INC	1,231	1,570
77313F106 ROCKET PHARMACEUTICA	358	509
78440X887 SL GREEN REALTY CORP	2,618	3,252
80874P109 SCIENTIFIC GAMES COR	3,165	3,120
825704109 SI BONE INC	1,250	1,050
82900L102 SIMPLY GOOD FOODS CO	3,186	3,406
829073105 SIMPSON MFG CO INC	1,291	2,178
830940102 SKYWARD SPECIALTY IN	2,901	3,456
85254J102 STAG INDUSTRIAL INC	2,438	2,827
86800U104 SUPER MICRO COMPUTER	1,383	1,706
89377M109 TRANSMEDICS GROUP IN	1,456	1,815
896945201 TRIPADVISOR INC COM	1,702	1,679
92047W101 VALVOLINE INC	24,156	23,675
92243G108 VAXCYTE INC COM	2,032	2,638
942749102 WATTS WATER TECHNOLO	25,938	31,459
G01767105 ALKERMES PLC	706	721
G25457105 CREDO TECHNOLOGY GRO	1,734	1,947
G3323L100 FABRINET	25,428	24,743
G6700G107 NVENT ELECTRIC PLC	28,375	29,959
G8068L108 SHARKNINJA INC	2,935	3,428

Description	Revenue And Expenses Per Books	Net Investment Income
OTHER INCOME	425	425
FEDERAL TAX REFUND	4,306	0
CARLYLE PE ACCESS DISTRIBUTIONS	21,695	21,695